NEWLAND PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.88 CNY | +5.46% |
|
+8.04% | -4.47% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2022 | 627M 86.66M | Sales 2023 | 651M 89.98M | Capitalization | 4.16B 575M |
|---|---|---|---|---|---|
| Net income 2022 | 132M 18.23M | Net income 2023 | 159M 21.96M | EV / Sales 2022 | 4.95 x |
| Net cash position 2022 | 747M 103M | Net cash position 2023 | 857M 118M | EV / Sales 2023 | 5.07 x |
| P/E ratio 2022 |
22.4
x | P/E ratio 2023 |
26.3
x | Employees | 1,010 |
| Yield 2022 |
1.73% | Yield 2023 |
1.92% | Free-Float | 21.38% |
More Fundamentals
* Assessed data
More news
| 1 day | +5.46% | ||
| 1 week | +8.04% | ||
| 1 month | +9.05% | ||
| 3 months | +43.85% | ||
| 6 months | -11.25% | ||
| Current year | -4.47% |
1 week
18.69
20.31
1 month
15.4120.31
Current year
13.0221.23
1 year
13.0231.48
3 years
13.0234.67
5 years
13.0234.67
10 years
13.0234.67
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-30 | 19.88 | +5.46% | 10,774,070 |
| 24-04-29 | 18.85 | +2.45% | 4,900,995 |
End-of-day quote Shenzhen S.E., April 29, 2024
More quotes
Newland Pharmaceutical Co Ltd, formerly Henan Newland Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical research and development. The Company's main business is the research and development, production and sales of pharmaceutical intermediates. The Company's main products are L-p-hydroxyphenylglycine series products and p-toluenesulfonic acid, including D-acid, methyl ester and hydroxydeng salt. The Company also produces pharmaceutical resolution agents. The Company mainly operates its businesses in the domestic and overseas markets.
Sector
Pharmaceuticals
Calendar
2024-08-22
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -4.47% | 550M | |
| +26.08% | 662B | |
| +21.85% | 546B | |
| -4.77% | 359B | |
| +16.97% | 323B | |
| +5.69% | 290B | |
| +13.68% | 234B | |
| +3.65% | 198B | |
| -11.12% | 194B | |
| +8.08% | 167B |
- Stock Market
- Equities
- 301277 Stock
